Category Archives: Uncategorized

In a landmark move, India and South Africa on 2 October asked the World Trade Organization (WTO) to allow all countries to choose to neither grant nor enforce patents and other intellectual property (IP) related to COVID-19 drugs, vaccines, diagnostics and … Continue reading →

Fourth year medical student and President, Students Involved in Rational Health Activities (SIRHA), Chamath Lavinda has written a brief history of  Sri Lankan national drug policy. He  describes Professor Bibile as the seed that produced a tree that bore the … Continue reading →

by Ellen ‘t Hoen, Director, Medicines Law & Policy Read the complete blog published in The Wire here On October 2, India and South Africa sent a proposal to the World Trade Organisation (WTO), asking that it allow countries to suspend the protection … Continue reading →

On October 2, the Indian Medical Association (IMA) released a poster carrying the names and photographs of 515 doctors — 492 males and 23 females — who died on the line of duty while treating Covid-19 patients. The poster is … Continue reading →

1. A report prepared by the Medicine Quality Research Group, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford of products that have been found to be poor quality or falsified in some way during the pandemic. The July report including … Continue reading →

Dr B Ekbal has recently published this article in Peoples’ Democracy.At a recent press conference, Kerala Chief Minister Pinarayi Vijayan made an important announcement with global political dimensions. He said that the monopoly drug manufacturers are engaged in developing vaccines, … Continue reading →

The South Centre is pleased to announce the publication of Policy Brief No. 76 entitled “Evolution of Data Exclusivity for Pharmaceuticals in Free Trade Agreements” by Wael Armouti, former Legal Affairs Director at Jordan Food and Drug Administration, Companies General Controller. Free trade agreements (FTAs) … Continue reading →

The attention on (hydroxy) chloroquine as a potential treatment in COVID-19 has become a serious problem:–  the evidence for its usefulness is very weak; the original study has several weaknesses–   this essential medicine is now very hard to get as … Continue reading →

It is with enormous sadness that we say farewell to Martin Khor. Many will have known Martin since our HAIAP beginnings. In the words of Zafrullah Chowdhury  ‘We are losing the very best amongst us, and that too at a … Continue reading →

https://www.who.int/news-room/detail/27-02-2020-who-launch-e-eml 27 February 2020The World Health Organisation has launched a new easy-to-access, digital version of its Model list of Essential Medicines (EML). The move will revolutionise the way this core WHO reference tool is used. More than 150 countries currently … Continue reading →